Dr.Timothy McCaffrey
Professor of Microbiology, Immunology, and Tropical Medicine and Medicine
Microbiology, Immunology, and Tropical Medicine
- Professor of Microbiology, Immunology, and Tropical Medicine and MedicineMicrobiology, Immunology, and Tropical Medicine
ABOUT
Tim McCaffrey, Ph.D. received his B.A. from St. Mary's University, and his Masters and Doctorate from Purdue University. He received Post-Doctoral training at Cornell University Medical College in New York City, where he stayed as an Assistant and then Associate Professor in the Department of Medicine. He founded the Genomics Core Facility at Weill/Cornell Medical School, which has since grown into affiliations with the New York Genome Center.
In 2001, he relocated his laboratory to The George Washington University Medical Center where he founded the Genomics Core Facility. In 2004, he was named Director of the Catherine Birch McCormick Genomics Center at GWU and Vice-Chairman for Research and Administration in the Department of Biochemistry and Molecular Biology. For 10 years, Dr. McCaffrey held a prestigious NIH-MERIT Award given to a select group of scientists in the top 1% of NIH-funded researchers.
He has recently formed a clinical and translational Division of Genomic Medicine within the Department of Medicine to capitalize on the rapidly expanding successes in genomically-guided diagnosis and prognosis. Dr. McCaffrey's research is focused on genetic regulation during the development of atherosclerotic lesions. He is working to exploit our understanding of these mechanisms for the development of new drug targets to treat cardiovascular disease, as well as for creating new diagnostic tests for predicting people who are at risk of developing heart disease.
Dr. McCaffrey works closely with The St. Laurent Institute, which supports cutting-edge research in areas such as neurodegenerative disease, ADHD, autism, and cardiovascular disease. He is an advisor to several start-up and established companies in the genomic and personalized medicine areas, such as SeqLL, formerly Helicos Technologies, and True Bearing Diagnostics, a start-up RNA diagnostics company.
SCHOOL
- School of Medicine and Health Sciences
SUSTAINABLE DEVELOPMENT GOALS
- 3 Good Health and Well Being